← Search & browse all drugs
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › IMMUNOSTIMULANTS › IMMUNOSTIMULANTS › Other immunostimulants
tasonermin
L03AX11
Forms & Strengths
- Recombinant human keratinocyte growth factor
- External gel formulation
Adult Dosing
- Apply topically to wound area
- Dosing regimens vary based on wound severity and size
Pediatric Dosing
- Safety and efficacy in pediatric patients not established
Indications
- Treatment of epidermolysis bullosa
- Treatment of venous ulcers
- Treatment of diabetic foot ulcers
Mechanism of Action
- Stimulates keratinocyte proliferation and differentiation
- Enhances wound healing
Contraindications
- Hypersensitivity to tasonermin or any component
- Malignant or suspected malignant wounds
Adverse Reactions
- Pain at application site
- Erythema
- Pruritus
Drug Interactions
- None well-documented
- Theoretical potential for interaction with other growth factors
Curated Content: Needs Vetting Before Put to Clinical Use